JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Vibecotamab is a bispecific chimeric monoclonal antibody which targets Interleukin-3 receptor subunit alpha and T-cell surface glycoprotein CD3 epsilon chain.